This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
11-13 November 2025
Congress Center BaselBasel, Switzerland

Dr. Nathalie Grob, PhD
Assistant Professor at ETH Zurich
Speaker

Profile

Nathalie Grob earned her BSc in Pharmaceutical Sciences and MSc in Pharmacy from the University of Basel, Switzerland. She pursued a PhD at ETH Zürich, Switzerland with Prof. Roger Schibli and Prof. Thomas Mindt to work on the development of radiolabeled peptides for cancer diagnosis and treatment. From 2020–2023, Nathalie Grob was a postdoctoral researcher in the group of Prof. Bradley Pentelute at the Massachusetts Institute of Technology, USA. Her postdoctoral research focused on methods for drug discovery of small molecules and peptides. In April 2024, she launched her independent research group for “Peptide-Based Drug Discovery” in the Department of Chemistry and Applied Biosciences at ETH Zürich as an Assistant Professor supported by a Starting Grant of the Swiss National Science Foundation.